Real-world outcomes of adjuvant gemcitabine versus gemcitabine plus capecitabine for resected pancreatic ductal adenocarcinoma.

Sora KangChanghoon YooSo Heun LeeDongwook OhTae Jun SongSang Soo LeeJae Ho JeongDo Hyun ParkDong Wan SeoJin-Hong ParkDae Wook HwangKi Byung SongJae Hoon LeeWoohyung LeeBong Jun KwakSarang HongHeung-Moon ChangBaek-Yeol RyooKyu-Pyo KimSong Cheol Kim

Published in: Therapeutic advances in medical oncology (2022)

Adjuvant GemCap showed the consistent clinical outcomes with the ESPAC-4 trial. As mFOLFIRINOX is the new standard treatment for medically fit patients with resected PDAC, further evaluation of optimal adjuvant chemotherapy in daily practice is warranted.

Keyphrases

locally advanced
early stage
lymph node
phase iii
healthcare
primary care
clinical trial
study protocol
rectal cancer
physical activity
phase ii
type diabetes
randomized controlled trial
metastatic colorectal cancer